December 
Because of the unexpected reduction in the amount of available inactivated influenza vaccine for the 2004-05 influenza season, on October 5, 2004 , the Advisory Committee on Immunization Practices (ACIP) recommended that the vaccine be reserved for persons in certain priority groups and asked others to defer or forego vaccination (1) . To assess the use of influenza vaccine and the primary reasons reported for not receiving vaccine, beginning November 1, questions were added to the ongoing Behavioral Risk Factor Surveillance System (BRFSS) survey. This report analyzes data collected during December 1-11 on self-reported vaccination during September 1-November 30, which indicated that persons in nonpriority groups had largely deferred vaccination and that, among unvaccinated adults in priority groups, one fourth tried to get vaccine but were unable to do so. Vaccination coverage was suboptimal for persons in all assessed priority groups. Because influenza activity peaks in February or later in most years (2) , persons in priority groups should continue to seek vaccination.
BRFSS is a monthly, state-based, random-digit-dialed telephone survey of the U.S. civilian, noninstitutionalized population aged >18 years, with an average of 20,000 completed surveys per month (3, 4) . In previous influenza seasons, the BRFSS survey included two questions on influenza vaccination coverage among adults: "During the past 12 months, have you had a flu shot?" and "During the past 12 months, have you had a flu vaccine that was sprayed in your nose?" Questions on health-risk status were limited, and no information was collected on the timing of vaccination or on influenza vaccination among children.
Beginning November 1, the two influenza vaccination questions were also asked regarding a randomly selected child in the household. In addition, new questions for adults and children were asked to determine 1) the month and year of the most recent influenza vaccination, 2) whether persons were vaccinated for influenza during the 2003-04 influenza season, 3) the primary reason vaccination was not received, and 4) whether the respondent (or a child in the household) was in one of the following ACIP-designated priority groups for vaccination: persons aged >65 years or aged 6-23 months, persons aged 2-64 years with one or more conditions that increase risk for influenza complications, health-care workers with patient contact, and household contacts of children aged <6 months*. For adults, conditions considered as increasing risk for influenza complications were asthma, other lung problems, heart problems, diabetes, kidney problems, weakened immune system, anemia, and pregnancy. For children, these conditions (with the exception of pregnancy) and aspirin therapy were considered as increasing risk for influenza complications. Children aged 6 months-8 years are recommended to have 2 doses of influenza vaccine if they have never been vaccinated for influenza (2) . However, in this survey, assessment of 1 versus 2 doses was not made, and children * Certain additional priority groups cited by ACIP were not included in the survey, including residents of nursing homes and long-term-care facilities, outof-home caregivers for children aged <6 months, and child household contacts of children aged <6 months.
* Proposed.
were counted among those vaccinated if they received any influenza vaccination. The analyses were based on 16,713 interviews conducted during December 1-11 and thus represent partial influenza season estimates. Data were available for 48 states and the District of Columbia; data for Nevada and New Mexico were not available. Because BRFSS data collection is ongoing, response rates for December are not yet available. The median response rate for states/areas for the preceding month (November 2004) was 52.3% (range: 23.2%-76.8%) based on CASRO guidelines. For 2003, the last year for which yearly response rates are available, the median response rate for states/ areas was 53.2% (range: 34.4%-80.5%). Although response rates have declined over time, when BRFSS data are compared with census data and other surveys, BRFSS data have a minimal bias and are reliable (3, 4) . Estimates were adjusted to account for differential probabilities in the sample selection, the age-and sex-specific population from the 2003 census for each state, and the size of the state population. Statistical analysis software was used to account for the complex sampling design and to calculate standard errors and confidence intervals.
Vaccination Coverage Among Adults
Among adults in all priority groups, 34.8% reported receiving an influenza vaccination during September 1-November 30, compared with 4.4% of adults aged 18-64 years who were not in a priority group (Table 1) . Coverage was highest (51.1%) among persons aged >65 years, followed by health-care workers with patient contact (34.2%) and adults aged 18-64 years with high-risk conditions (19.3%). The percentage of persons reporting that they obtained an influenza vaccination during September 1-November 30 was smaller in each of these groups than the percentage who said they obtained a vaccination during the previous influenza season, September 1, 2003 -March 31, 2004 . Among persons aged >65 years who reported receiving influenza vaccine during the 2003-04 influenza season, 71.7% reported also being vaccinated during the 2004-05 influenza season. State-specific, self-reported vaccination coverage among adults in priority groups ranged from 18.0% to 60.3%, with a median of 37.6% ( Figure) . Among all vaccinated adults, 1.6% reported receiving FluMist ® , the live attenuated influenza vaccine (LAIV) approved for use by healthy persons aged 5-49 years who are not pregnant and not contacts of severely immunocompromised persons.
Among adults in priority groups who had not yet received influenza vaccine, 23.3% reported that they attempted to obtain vaccination but could not; among persons aged >65 years, the proportion was 32.5% (Table 2) . Among adults not in a priority group who had not received vaccine, 10.4% reported that they attempted to obtain vaccination but could not. Among adults in priority groups, 10.0% of adults said they were saving the vaccine for others, and 6.5% thought that they were not eligible to receive the vaccine.
Vaccination Coverage Among Children
A substantially greater proportion of children in priority groups received at least one influenza vaccination this season compared with other children; 36.6% of children aged 6-23 months and 26.8% of children aged 2-17 years with highrisk conditions were vaccinated, compared with 8.9% of children aged 2-17 years with no high-risk condition (Table 3) . Among those children aged 2-17 years with high-risk conditions who were vaccinated for influenza during the 2003-04 influenza season, 51.6% also have been vaccinated thus far this season.
Among respondents with an unvaccinated child aged 6-23 months, 62.9% reported that they thought the vaccine was not needed, 8 .4% reported that they tried but could not obtain vaccination for the child, 1.0% thought the child was ineligible for influenza vaccination, and 0.3% said they were saving the vaccine for those who needed it (Table 4) . For respondents with an unvaccinated child aged 2-17 years with a high-risk condition, 38.4% reported that they thought vaccination was not needed, 14.4% reported that they tried but could not obtain vaccination, 12.5% thought their child was not eligible, and 10.3% said they were saving the vaccine for others. ¶ Asthma, other lung problems, heart problems, diabetes, kidney problems, weakened immune system, anemia, or pregnancy. ** Self-reported description might include doctors, nurses, laboratory workers, and office receptionists. † † Persons can be included in more than one priority group. § § Includes persons with children aged <6 months in the household; stable estimates for this group could not be estimated separately because of its small sample size. (2) . However, the majority (62.6%) of respondents with unvaccinated children aged 6-23 months did not think vaccination was needed for those children, indicating that further efforts are needed to educate the public about the new influenza vaccination recommendation for young children.
FIGURE. Percentage of adults in priority groups
The findings in this report are subject to at least four limitations. First, BRFSS is a land-line telephone-based survey and excludes those segments of the population without telephones or who use only cellular telephones. Second, data are self reported and subject to recall bias, particularly for questions that require recall over a longer period; therefore, for certain behaviors, prevalence estimates might be under-or overestimated. Third, certain influenza vaccine priority groups were not considered in the survey, including institutionalized adults and adult caretakers of children aged <6 months outside of the home (e.g., child care workers). Finally, because interviewing is not yet completed for December, these estimates might be subject to nonresponse bias if the responses from those who will be interviewed later in the month differ substantially from the results in this report. However, these vaccination coverage estimates are higher than estimates from BRFSS data collected in November and are consistent with public health messages encouraging those in priority groups to seek vaccination and asking others to forego vaccination.
Estimates from BRFSS data of vaccination coverage for certain priority groups differ from those obtained by the influenza survey of the Harvard School of Public Health (HSPH), also published in this issue (6) . The methodologies used in these surveys differ in at least three important respects, which might contribute to the differences in results. First, the interviews were conducted at different times and provide estimates of vaccination coverage at different points in the 2004-05 influenza season. BRFSS was conducted during December 1-11; the HSPH survey was conducted during October 29-November 9. Second, BRFSS data were collected individually by 48 states and the District of Columbia and reflect the combined responses of more than 16,713 adults; the HSPH survey was a national survey of 1,227 adults. Finally, the two surveys differed in how they measured the impact of the vaccine shortage on vaccination coverage. BRFSS asked a single, open-ended question of adults and one of adults residing with children to assess the primary reason persons had not received vaccination as of the date of interview. HSPH used a more extensive series of questions to assess the impact of the shortage.
Influenza vaccination coverage estimates from this survey, when applied to U.S. population estimates for each of the priority and nonpriority groups, indicate that an estimated 45 million doses of influenza vaccine had been administered to noninstitutionalized persons as of November 30; approximately 73% of these doses were obtained by persons in priority groups. An estimated 58 million doses of inactivated vaccine and up to 3 million doses of LAIV are expected to be available for the United States for this influenza season. Thus, adequate doses of vaccine appear to remain to meet the anticipated demand among priority groups for influenza vaccination, based on 2003-04 coverage estimates from this survey. Although the survey did not assess coverage among institutionalized persons in priority groups, this projection also suggests that vaccine should be available to meet the demand of the nation's approximately 1.5 million nursing home residents. In addition, use of LAIV is an option for the vaccination of persons in certain priority groups (e.g., healthcare workers who do not work with severely immunocompromised persons and household contacts of children aged <6 months). LAIV is approved by the Food and Drug Administration for use among healthy persons aged 5-49 years who are not pregnant.
Geographic differences in vaccine distribution and demand exist. To ensure that all available vaccine is used, state or local public health officials who determine that all persons in priority groups seeking vaccine have received vaccination and additional vaccine remains on hand might choose to recommend limited expansion of vaccination eligibility in their areas. Such expansion might include persons aged 50-65 years, household contacts of persons in priority groups, or other populations considered at increased risk by state or local officials. However, even if such a recommendation is made, private providers with large volumes of unused vaccine should, wherever practical, work with the state to transfer these doses to other states with unmet needs among persons in the ACIP priority groups.
CDC continues to work with manufacturers, distributors, and state immunization programs to distribute vaccine to those states with unmet demand among the priority groups. Until the demand for vaccine has been met for all persons in ACIP priority groups in all states, vaccine held in the public sector should continue to be shared with those states whose vaccine supply is not sufficient to cover their priority groups. Persons with questions regarding influenza vaccine availability should contact their state and local health departments.
Experiences with Obtaining Influenza Vaccination Among Persons in Priority Groups During a Vaccine Shortage -United States, October-November, 2004
After the announcement that the supply of inactivated influenza vaccine available to the U.S. public for the 2004-05 influenza season would be reduced by approximately one half, the Advisory Committee on Immunization Practices (ACIP) recommended that the remaining vaccine supply should be reserved for 1) certain groups of persons at high risk for serious health problems from influenza, 2) healthcare workers involved in direct patient care, and 3) close contacts of children aged <6 months (1) . To determine what proportion of persons at increased risk for influenza complications had been vaccinated as of the day of the survey, what proportion sought vaccination but did not receive it because of the shortage, and what factors might be dissuading persons at high risk from seeking influenza vaccination, Harvard School of Public Health (HSPH), in collaboration with International Communications Research, conducted a national survey. This report summarizes the results of that survey, which indicated that approximately 63% of persons aged >65 years and 46% of chronically ill adults who tried to get the influenza vaccine were able to do so. More than half of adults at high risk did not try to get the influenza vaccine. Because available supplies of inactivated influenza vaccine are targeted to high-risk groups, persons in these groups should continue to pursue vaccination.
HSPH provides CDC with technical assistance for public health communication by monitoring the response of the general public to public health threats. National polling on what the public knows, believes, and experiences in regard to seeking and receiving influenza vaccination during a national vaccine shortage is the basis of the data presented in this report.
During October 29-November 9, 2004, telephone interviews were conducted to assess experiences of respondents with obtaining the influenza vaccine. The survey was conducted by International Communications Research as part of an omnibus survey. The omnibus survey is a national, biweekly telephone survey that can include questions on several topics; however, because of the length of the questionnaire, the omnibus survey regarding influenza vaccination only included the HSPH questions. Respondents were asked 1) if they tried to get the influenza vaccine during the preceding 3 months, 2) if so, whether they were able to get the vaccine, and 3) whether they experienced any problems while trying to get the vaccine. Respondents who did not try to get the vaccine were asked why they did not. Respondents were also asked about their willingness to receive an imported influenza vaccine not licensed for general use in the United States. Parents of children aged 6-23 months were asked these questions about their children in that age group.
The questionnaire was administered to adults aged >18 years who were selected by using a fully replicated, stratified, singlestage, random-digit-dialing sample of households nationally*. Within each household, an adult respondent was randomly selected by asking for the adult with the most recent birthday. A total of 1,227 adults completed interviews. This group included an oversample of parents with children aged 6-23 months. A total of 249 interviews were completed with this latter group. Parents were asked vaccine-related questions about each of their children in the age group.
The data analysis targeted three groups at high risk included among those prioritized by ACIP for influenza vaccination in 2004: 1) persons aged >65 years, 2) persons aged 18-64 years with underlying chronic medical conditions, and 3) children aged 6-23 months. The data were weighted to account for the disproportionate probability of household selection attributable to multiple telephone lines and the probability associated with the random selection of an individual household * Similar questions were asked in the Behavioral Risk Factor Surveillance System survey reported in this issue of MMWR (2).
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member. Following the application of the above weight, the sample was post-stratified and balanced by age, sex, race/ ethnicity, education, region, census division, and metropolitan status to be nationally representative. Statistical software was used to calculate standard errors for weighted data. Confidence intervals (CIs) also were calculated.
Adults in Priority Groups
Among adult respondents, 242 (19%) were aged >65 years; 306 (25%) had been told by a doctor that they had one of the following health conditions: heart or lung disease, asthma, kidney disease, diabetes, or a disease that causes decreased immunity (e.g., cancer or HIV/AIDS). For this analysis, these groups were combined and referenced as adults at high risk (n = 427), unless otherwise noted.
Among adults aged >65 years, 119 (49%) tried to get the influenza vaccine during the preceding 3 months. Among those in this age group who tried to get the vaccine, 75 (63%) were able to get the vaccine, and 44 (37%) were unable to do so. A total of 113 (37%) adults with a chronic illness tried to get the vaccine; among those who tried to get the vaccine, 52 (46%) were able to get it, whereas 61 (54%) reported being unable to do so (Table 1) .
Respondents were asked to rate problems as either major problems they experienced when trying to get the vaccine, minor problems, or not problems at all ( Table 2) . The leading problems experienced by the 81 adults at high risk who tried and could not get the vaccine included the following: 1) no vaccine was available when they tried to get it (55 [68%] cited this as a major problem) and 2) finding a place where they could get the vaccine was difficult (41 [50%]). It was hard to find a place where you could 50 (37-64) get the vaccine.
The times that the vaccine was available 24 (12-36) were inconvenient.
The health-care provider told you that you 15 (5-24) should not get one because there were shortages and you were not at high risk for having a serious case of influenza.
The vaccine was expensive. 4 (0-10)
The health-care provider told you that you 4 (1-8) should not get one for medical reasons. * Confidence interval.
Among the 427 adults at high risk as defined above, 257 (60%) (CI = 54%-66%) reported that they did not try to get the influenza vaccine during the preceding 3 months. Awareness of the influenza vaccine shortage was an important reason cited for not trying to get the vaccine: 82 of these 257 (32%) (CI = 24%-40%) said either that they were waiting until more vaccine was available or that they believed that, because of shortages, they could not get the vaccine. Other major reasons included 1) believing that they were not at high risk for getting a serious case of influenza (53 [21%]; CI = 14%-27%), 2) not believing that the vaccine would be effective in preventing them from getting influenza (45 [18%]; CI = 11%-25%), and 3) concerns that they could get influenza from the vaccine (46 [18%]; CI = 12%-25%).
Children Aged 6-23 Months
Of parents with children aged 6-23 months, 125 (50%) (CI = 39%-59%) tried to get the vaccine for their child; 95 (76%) of those parents who tried to get the vaccine for their child reported that they were able to get the influenza vaccine, and 30 (24%) reported that they were unable to do so (Table 1) .
Few problems were reported by parents who tried to get the vaccine. A total of 14 (11%) (CI = 1%-17%) parents who tried to get the vaccine for their child reported problems, including 1) difficulty finding vaccine, 2) inconvenient times, and 3) a health-care provider advising against their child receiving vaccine because of the shortages or for a medical reason.
For children aged 6-23 months, the leading reasons for not trying to get inactivated influenza vaccine reported by parents were 1) not believing their children were at risk for a serious case of influenza (26 [21%]; CI = 10%-37%); 2) concern about the side effects (24 [19%]; CI = 6%-32%); 3) being told by a health-care provider that the child should not get the vaccine because of the shortages and because the child was not at high risk for having a serious case of influenza (22 [18%]; CI = 7%-34%); and 4) not believing that the influenza vaccine was effective (16 [13%] ; CI = 4%-22%).
Importation of Influenza Vaccine Not Licensed by FDA
To ease the vaccine shortage in the United States, the U.S. government has announced its intention to import from Germany influenza vaccine not licensed by the Food and Drug Administration (FDA). The vaccine, Fluarix ™ (GlaxoSmithKline, Dresden, Germany), although fully licensed for use in Germany, is not approved for general use in the United States and is therefore considered to be investigational. Respondents were asked if they would be willing to take the vaccine after being told that the vaccine was investigational. Fifty-six percent (CI = 49%-63%) of adults at high risk said they would be willing to receive this vaccine if no other vaccine were available. U.S. persons who elect to receive investigational vaccines are required to sign a form. With this requirement imposed, willingness to take the vaccine decreased to 40% (CI = 34%-46%) among adults at high risk. Editorial Note: The findings in this report suggest that, during the current vaccine shortage, approximately 63% of persons aged >65 years and 46% of chronically ill adults who tried to get the influenza vaccine were able to do so. However, more than half of adults at high risk did not try to get the influenza vaccine. For many of these respondents, this was because of perceived shortages, underscoring the need to continue to encourage these groups to pursue vaccination. Efforts to vaccinate these groups should include measures to educate them about the severity of influenza and the effectiveness of the vaccine and address unwarranted fears of getting influenza from the vaccine. Finally, the reluctance expressed by adults in priority groups about receiving imported influenza vaccine not licensed by FDA suggests the need for educational efforts to provide reassurance that this vaccine is approved for use in Germany by government agencies similar to the FDA.
In 2004, for the first time, ACIP recommended that children aged 6-23 months be vaccinated. The findings in this report suggest that parents of children in this age group who tried to get the vaccine for their children experienced fewer difficulties in getting the vaccine than persons aged >65 years or those with chronic illnesses.
The findings in this report are subject to at least two limitations. First, because the study was conducted as part of an omnibus survey, the data are not collected in a way that allows for the calculation of the response rate. However, studies have indicated that when the results from a survey with a long field period and high response rate are compared with a survey with a field time that is similar to the HSPH survey, few statistically significant differences are observed between responses from the two surveys when the data are statistically reweighted (3) (4) (5) (6) . Second, the survey sample included only noninstitutionalized persons. Nursing home residents, who are excluded from the sample, might receive the influenza vaccine at a different rate than those in the study sample.
The results of the HSPH survey differ from those of the Behavioral Risk Factor Surveillance System (BRFSS) survey, also published in this issue (2) . Important differences in survey methodologies might contribute to the differences in results. The primary differences are that 1) the surveys were conducted during different periods (i.e., October 29-November 9 for HSPH and December 1-11 for BRFSS); 2) somewhat different questions were asked; and 3) the HSPH data came from a single, national sample, but BRFSS data were collected individually by 48 states and the District of Columbia. Despite these differences, both surveys demonstrate a substantial need for the influenza vaccine that has not been met.
Assuming that an adequate vaccine supply will be available for persons in priority groups this season, health-care providers should continue to emphasize 1) the need for these groups to get vaccinated this season and 2) the availability of vaccine allowing all persons in these groups to get vaccinated. Influenza vaccine should continue to be directed to areas most affected by the shortage.
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Experiences with Influenza-Like Illness and Attitudes Regarding Influenza Prevention -United States, 2003-04 Influenza Season
Despite advances in medical treatment, influenza results in approximately 36,000 deaths each year in the United States (1). Vaccination has been a mainstay of influenza prevention, with annual vaccination recommended for adults and children at high risk; efforts to interrupt person-to-person transmission are also important. In October 2003, CDC recommended that health-care facilities implement a Universal Respiratory Hygiene Strategy, including providing masks or facial tissues in waiting rooms to persons with respiratory symptoms (2) . To gather information on influenza-like illness (ILI) and attitudes regarding prevention of ILI (including use of vaccine and respiratory hygiene), CDC and 11 Emerging Infections Programs (EIPs) conducted a random-digit-dialed telephone survey of noninstitutionalized U.S. civilian adults in February 2004. This report summarizes the results of that survey, which determined that 43% of adults and 69% of children aged 6 months-17 years with ILI visited a healthcare provider for the illness. Eight percent of adults with ILI reported having been asked by a health-care provider to wear a mask; 82% said they would wear a mask if requested. With the limited availability of influenza vaccine this season, the use of masks by persons with cough illnesses in health-care settings, a component of the Universal Respiratory Hygiene Strategy, might be a helpful and acceptable method for decreasing influenza transmission.
EIP is a population-based network consisting of CDC, state health departments, and local collaborators to assess the impact of emerging infections and evaluate methods for their prevention and control (3) . For this survey, data were collected from a stratified random sample of telephone-equipped households in all 11 EIP surveillance areas* that covered selected counties of certain states and the entire populations of others. During February 6-22, 2004, a total of 200 eligible households in each area were selected by list-assisted randomdigit-dialing from a sampling frame of possible telephone numbers filtered to eliminate unused or business exchanges. When an adult in an eligible household declined to participate or could not be contacted after six attempts, a substitute number was selected randomly from the list. The survey was confidential, and respondents gave consent for participation. One English-speaking adult aged >18 years was interviewed in each participating household. The survey assessed ILI by self-report, visits to health-care providers, prescription of medication for self-reported ILI, attitudes about vaccination against influenza, and willingness to take measures that might prevent influenza transmission. Questions addressed the period October 1, 2003, through the time of the interview in February 2004. Data were weighted to reflect the age, sex, and racial/ ethnic distributions of the population of each area. Proportions, risk ratios, and confidence intervals were calculated by statistical software.
A total of 2,231 surveys were completed. Among eligible respondents, 48.7% consented to participate. The median age of respondents was 43 years (range: 18-97 years), and 51.3% were female. The proportion of surveyed adults who responded "yes" to the question "Have you had an illness you thought was the flu at any time since October?" was 17.8% (Table 1) . Of these, 53.2% reported having a sudden high fever with cough or sore throat. For the 811 households with at least one child aged 6 months-17 years at the time of interview, one child was randomly selected; of these, 23.9% had ILI from October 2003 through the time of the interview. Among children with reported ILI, 68.9% had symptoms of fever with cough and/or sore throat. On average, reported ILI occurrence among children and adults peaked during December 2003.
Of those for whom ILI was reported, 43.3% of adults and 69.2% of children visited a health-care provider for the illness ( Table 1 ). The provider reportedly told 64.5% of these adults and 47.6% of these children that they had influenza; 37.2% of adults with a clinical diagnosis of influenza were tested for influenza, compared with 65.0% of children. Of adults who visited a provider, 85.9% received a prescription for medication, most commonly an antibiotic (33.1%).
Approximately 8.2% of adults who visited a health-care provider for ILI said they were asked to wear a mask; 82.4% of all respondents said they would wear a mask while waiting at the doctor's office or hospital if asked to by their healthcare provider (Table 2) . Fewer respondents agreed with the statements "people with a cough should wear a mask while waiting to see a health-care provider" and "people who are sick and able to spread germs should wear a mask in public" (62.8% and 59.0%, respectively).
Approximately 70% of all respondents said they believed the influenza vaccine for the 2003-04 season was "somewhat" or "very effective," 32.8% said they believed the influenza vaccine causes influenza, and 10.7% reported experiencing prob-Editorial Note: The 2003-04 influenza season was notable for several reasons: 1) in certain states, the season began as early as October; 2) a suboptimal antigenic match between the dominant influenza A (H3N2) subtype circulating in the community (Fujian/411/2002) and that in the vaccine (Panama/2007/99) occurred; and 3) early reports of deaths among children helped create a high demand for vaccine (4) . Because of these factors, the media focused substantial attention on influenza and vaccination. This setting provided an opportunity to evaluate the acceptability of influenza prevention measures among the public.
Droplets of respiratory secretions are believed to be the primary means of person-to-person influenza transmission; spread can also occur through direct person-to-person contact or through fomites (5). For periods of increased respiratoryinfection activity, the Universal Respiratory Hygiene Strategy recommends that health-care facilities provide masks or facial tissues to persons who are coughing and that hand-hygiene agents (e.g., alcohol-based hand gels) be readily available (2). 
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Use of surgical masks by health-care professionals to protect against infection with influenza and other respiratory pathogens is also an established component of hospital infection control (6); however, its effectiveness in preventing transmission from influenza patients to others in outpatient settings has not been determined (4) . Hand washing has been demonstrated to be effective in reducing respiratory illness, and alcohol-based hand sanitizers can kill influenza viruses on hands; however, studies of hand-hygiene measures on influenza transmission are lacking (5,7). Likewise, few published data are available on the public's willingness to wear masks or use other measures to prevent transmission of respiratory illnesses.
The survey results indicated that at least 8% of respondents with ILI had been asked by their health-care providers to wear a mask while waiting to be examined, and more than 80% of respondents indicated a willingness to do so in the future. Information about the acceptability of such intervention measures might be useful in managing large outbreaks, including pandemic influenza. Although only 8% of those visiting a health-care provider for ILI were asked to wear a mask, many of those visits might have been to doctors' offices; mask usage might be higher in other health-care settings. Use of tissues for reducing droplet spread and use of hand-hygiene agents were not evaluated in this survey. With the limited availability of influenza vaccine this season, the use of masks by persons with cough illnesses in health-care settings and other components of the Universal Respiratory Hygiene Strategy (e.g., tissues and alcohol-based hand sanitizers) might help decrease influenza transmission.
The survey findings suggest that children were disproportionately affected by ILI during the 2003-04 season. Reported ILI was one third more common among children than adults, and reported symptoms in children were more frequently consistent with the ILI surveillance case definition (temperature >100.0°F [>37.8°C] and cough or sore throat in the absence of a known cause other than influenza). Health-care use (including provider visits, influenza testing, and hospitalization) was more common among children than adults with reported ILI. Recent recommendations for providing influenza vaccine to all young children were designed to address the substantial disease burden among this age group (1). More than one half of respondents from households with children said they would participate in annual influenza vaccination of children.
The findings in this report are subject to at least two limitations. First, certain sampling factors (low response rate, limited sampling area, and restriction to English-speaking respondents) might mean that some of the results are not representative of the entire U.S. population. Second, self-reported ILI symptoms are not specific for influenza; because other etiologic agents can cause influenza-like symptoms, the true incidence of influenza is expected to be lower (8) .
In addition to indicating that persons with respiratory illness might be willing to wear masks in health-care settings, the results of this survey also suggest opportunities for improving vaccination coverage. Although a majority of respondents said they believed the 2003-04 influenza vaccine was "somewhat" or "very effective," at least one tenth reported problems obtaining vaccine, and nearly one third reported believing that influenza vaccine causes influenza. Educational efforts about the effectiveness of influenza vaccination and improved supply and distribution of vaccine might improve vaccination coverage levels. 
Brief Report
Respiratory Syncytial Virus Activity -United States, 2003-2004
Respiratory syncytial virus (RSV) is a major cause of lower respiratory tract infections (LRTIs) (i.e., bronchiolitis and pneumonia) among young children, resulting in an estimated 51,000-82,000 hospitalizations annually (1). RSV causes severe disease among older adults and persons of all ages with compromised respiratory, cardiac, or immune systems, and can exacerbate chronic cardiac and pulmonary conditions (1-4) . In temperate climates, RSV infections occur primarily during annual winter season outbreaks. This report summarizes trends in RSV activity reported to the National Respiratory and Enteric Virus Surveillance System (NREVSS) during Because RSV infection only confers partial protection from subsequent infection, reinfections occur throughout life (3, 4) . As a result, health-care providers should consider RSV as a cause of acute respiratory disease in all age groups during community outbreaks, particularly in young children. Rapid diagnostic techniques for clinical use vary in sensitivity and specificity. Certain assays are sensitive for diagnosis in infants and young children, but few are sensitive for diagnosis in older children and adults. Polymerase chain reaction-based assays with enhanced product detection systems can be sufficiently sensitive to detect most infections in all age groups (7, 8) . Accurate diagnosis of RSV infection is crucial for appropriate infection control, to rule out cocirculating viruses (e.g., influenza viruses) and to avoid inappropriate use of antimicrobial agents. Infants and children at risk for serious RSV infection should receive monthly doses of humanized murine anti-RSV monoclonal antibody throughout the RSV season (6) . Infants and children at risk include those aged <24 months with chronic lung disease who have required medical therapy (e.g., supplemental oxygen, bronchodilator, diuretic, or corticosteroid therapy) within 6 months of RSV season onset and those with hemodynamically significant heart disease, and preterm infants born at <32 weeks' gestation or preterm infants born at 32-35 weeks' gestation with at least two additional risk factors (e.g., child care attendance, exposure to environmental pollutants, school-aged siblings, congenital abnormalities of the airways, or neuromuscular disease) during their first RSV season. Because the onset of RSV activity can vary between regions and communities, physicians and health-care facilities should consult their local clinical laboratories for the latest data on RSV activity (9) . Additional information and updates on RSV trends are available at http://www.cdc.gov/ncidod/dvrd/revb/nrevss/index.htm.
Notice to Readers
Where To Find Information on Influenza and Influenza Vaccine
To help the public locate the latest information about influenza, CDC has created a comprehensive website, available at http://www.cdc.gov/flu. The site contains information targeted to health-care professionals, as well as CDC influenza fact sheets and health education materials intended for the general public. The site is updated as new information becomes available.
CDC has also launched 800-CDC-INFO (800-232-4636), a new, central hotline with recorded information available in English and Spanish, available 24 hours a day, 7 days a week. Hotline callers can select voice messages on various influenzarelated topics, with the option to transfer for additional information. The number for hearing impaired persons is 800-243-7889 (TTY/TDD).
Any information CDC receives about problems finding influenza vaccine will be shared with state health officials to help direct available vaccine to persons and places where it is needed. 
